1. Home
  2. Labeler Index
  3. Merck Sharp & Dohme Llc
  4. 0006-3061
  5. NDC Package Code: 0006-3061-00 Emend

NDC Package 0006-3061-00 Emend

Fosaprepitant Dimeglumine Injection, Powder, Lyophilized, For Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0006-3061-00
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)
Product Code:
0006-3061
Proprietary Name:
Emend
Non-Proprietary Name:
Fosaprepitant Dimeglumine
Substance Name:
Fosaprepitant Dimeglumine
Usage Information:
Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Aprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
11-Digit NDC Billing Format:
00006306100
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1731077 - fosaprepitant 150 MG Injection
  • RxCUI: 1731077 - fosaprepitant 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
  • RxCUI: 1731082 - Emend 150 MG Injection
  • RxCUI: 1731082 - fosaprepitant 150 MG Injection [Emend Injection]
  • RxCUI: 1731082 - Emend 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Merck Sharp & Dohme Llc
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • FOSAPREPITANT DIMEGLUMINE 150 mg/5mL
    • Pharmacologic Class(es):
  • Cytochrome P450 2C9 Inducers - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inducers - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
  • Neurokinin 1 Antagonists - [MoA] (Mechanism of Action)
  • Substance P/Neurokinin-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA022023
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    02-03-2017
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0006-3061-00 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00006306100J1453Fosaprepitant injection1 MG11150150

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0006-3061-00?

    The NDC Packaged Code 0006-3061-00 is assigned to a package of 1 vial, single-dose in 1 carton / 5 ml in 1 vial, single-dose (0006-3061-01) of Emend, a human prescription drug labeled by Merck Sharp & Dohme Llc. The product's dosage form is injection, powder, lyophilized, for solution and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0006-3061 included in the NDC Directory?

    Yes, Emend with product code 0006-3061 is active and included in the NDC Directory. The product was first marketed by Merck Sharp & Dohme Llc on February 03, 2017 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0006-3061-00?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0006-3061-00?

    The 11-digit format is 00006306100. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20006-3061-005-4-200006-3061-00